Brazil puts extra weight behind cord blood programmes, stem cell R&D:
This article was originally published in Clinica
Executive Summary
The Brazilian cancer institute (INCA) has been given the go-ahead to expand the national umbilical cord and placental blood bank (BSCUP), in support of related healthcare and research programmes. The national economic and social development bank has approved a R$4.1m (US$1.8m) investment, which will enable BSCUP to increase its capacity from 3,000 to 10,000 units. The investment will be used to extend and improve facilities, in line with international processing and storage standards, the health ministry stated, to increase the activity of the national marrow transplantation centre (CEMO) and help establish the national blood banks network, Brasilcord. Brazil's stem cell research programmes will also benefit from these expansion plans, said the health ministry.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.